Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Deepak L Bhatt

Showing results (991-1000 of 1,708) with videos related to

Pageof 171
Sort By:
Clinical Cardiology|August 1, 2009
Hypercholesterolemia paradox in relation to mortality in acute coronary syndromeTracy Y Wang, L Kristin Newby, Anita Y Chen, et al.
The Journal of Invasive Cardiology|April 10, 2008
Efficacy of a novel procedure sheath and closure device during diagnostic catheterization: the multicenter randomized clinical trial of the FISH deviceAnthony A Bavry, Russell E Raymond, Deepak L Bhatt, et al.
Circulation|April 14, 2020
Clinical Management of Stable Coronary Artery Disease in Patients With Type 2 Diabetes Mellitus: A Scientific Statement From the American Heart AssociationSuzanne V Arnold, Deepak L Bhatt, Gregory W Barsness, et al.
JACC. Advances|May 30, 2025
An Observational Study of Cardiovascular Outcomes of Tirzepatide vs Glucagon-Like Peptide-1 Receptor AgonistsSourbha S Dani, Bhargav Makwana, Sumanth Khadke, et al.
Journal of the American College of Cardiology|March 5, 2025
Transcatheter Aortic Valve Replacement Beyond Severe Aortic Stenosis: JACC State-of-the-Art ReviewFrans J Beerkens, Gilbert H L Tang, Annapoorna S Kini, et al.
European Heart Journal|March 8, 2021
Percutaneous coronary intervention in patients with cancer and readmissions within 90 days for acute myocardial infarction and bleeding in the USAChun Shing Kwok, Chun Wai Wong, Evangelos Kontopantelis, et al.
Diabetes, Obesity & Metabolism|August 4, 2020
Effects of glucagon-like peptide-1 receptor agonists liraglutide and semaglutide on cardiovascular and renal outcomes across body mass index categories in type 2 diabetes: Results of the LEADER and SUSTAIN 6 trialsSubodh Verma, Darren K McGuire, Stephen C Bain, et al.
Nature Cardiovascular Research|June 13, 2025
Secondary analysis of the EMPACT-MI trial reveals cardiovascular-kidney efficacy and safety of empagliflozin after acute myocardial infarctionRahul Aggarwal, Deepak L Bhatt, Adrian F Hernandez, et al.
Clinical Cardiology|August 15, 2017
Study of young patients with myocardial infarction: Design and rationale of the YOUNG-MI RegistryAvinainder Singh, Bradley Collins, Arman Qamar, et al.
Circulation. Cardiovascular Interventions|December 17, 2017
Thirty-Day Readmission Rate and Costs After Percutaneous Coronary Intervention in the United States: A National Readmission Database AnalysisAvnish Tripathi, J Dawn Abbott, Gregg C Fonarow, et al.
Pageof 171

Showing results (991-1000 of 1,708) with videos related to

Sort By:
Pageof 171
Clinical Cardiology|August 1, 2009
Hypercholesterolemia paradox in relation to mortality in acute coronary syndromeTracy Y Wang, L Kristin Newby, Anita Y Chen, et al.
The Journal of Invasive Cardiology|April 10, 2008
Efficacy of a novel procedure sheath and closure device during diagnostic catheterization: the multicenter randomized clinical trial of the FISH deviceAnthony A Bavry, Russell E Raymond, Deepak L Bhatt, et al.
Circulation|April 14, 2020
Clinical Management of Stable Coronary Artery Disease in Patients With Type 2 Diabetes Mellitus: A Scientific Statement From the American Heart AssociationSuzanne V Arnold, Deepak L Bhatt, Gregory W Barsness, et al.
JACC. Advances|May 30, 2025
An Observational Study of Cardiovascular Outcomes of Tirzepatide vs Glucagon-Like Peptide-1 Receptor AgonistsSourbha S Dani, Bhargav Makwana, Sumanth Khadke, et al.
Journal of the American College of Cardiology|March 5, 2025
Transcatheter Aortic Valve Replacement Beyond Severe Aortic Stenosis: JACC State-of-the-Art ReviewFrans J Beerkens, Gilbert H L Tang, Annapoorna S Kini, et al.
European Heart Journal|March 8, 2021
Percutaneous coronary intervention in patients with cancer and readmissions within 90 days for acute myocardial infarction and bleeding in the USAChun Shing Kwok, Chun Wai Wong, Evangelos Kontopantelis, et al.
Diabetes, Obesity & Metabolism|August 4, 2020
Effects of glucagon-like peptide-1 receptor agonists liraglutide and semaglutide on cardiovascular and renal outcomes across body mass index categories in type 2 diabetes: Results of the LEADER and SUSTAIN 6 trialsSubodh Verma, Darren K McGuire, Stephen C Bain, et al.
Nature Cardiovascular Research|June 13, 2025
Secondary analysis of the EMPACT-MI trial reveals cardiovascular-kidney efficacy and safety of empagliflozin after acute myocardial infarctionRahul Aggarwal, Deepak L Bhatt, Adrian F Hernandez, et al.
Clinical Cardiology|August 15, 2017
Study of young patients with myocardial infarction: Design and rationale of the YOUNG-MI RegistryAvinainder Singh, Bradley Collins, Arman Qamar, et al.
Circulation. Cardiovascular Interventions|December 17, 2017
Thirty-Day Readmission Rate and Costs After Percutaneous Coronary Intervention in the United States: A National Readmission Database AnalysisAvnish Tripathi, J Dawn Abbott, Gregg C Fonarow, et al.
Pageof 171